Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3427 results

Sort By:

Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma

Study ID: NCT06933966
Start Date: 2025-09-01
End Date: 2032-09-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

observation alone

Sponsor

Center Leon Berard

Source: clinicaltrials.gov

Share:
Add to list

Why Calories Are Not the Same - a Gut Explanation?

Study ID: NCT06932666
Start Date: 2025-05-15
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Diet A group

Diet B group

Sponsor

University of Copenhagen

Source: clinicaltrials.gov

Share:
Add to list

Type 1 Diabetes and Obstructive Sleep Apnea

Study ID: NCT06915831
Start Date: 2025-06-15
End Date: 2029-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Continuous positive airway pressure (CPAP)

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

BC179 Against Alcohol-Induced Damage

Study ID: NCT06899620
Start Date: 2025-05-30
End Date: 2026-04-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Probiotic group

Placebo group

Sponsor

Wecare Probiotics Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

C-CAR168 CAR T Cell Therapy for Refractory Autoimmune Disease

Study ID: NCT06935474
Start Date: 2025-07
End Date: 2029-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

24

Intervention / Treatment

C-CAR168

Sponsor

AbelZeta Inc.

Source: clinicaltrials.gov

Share:
Add to list

The Oh Happy Day Class - Digital Connections (OHDC-DC): A Pilot Study

Study ID: NCT06206226
Start Date: 2025-07
End Date: 2026-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

8

Intervention / Treatment

OHDC-DC

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list

Immune Cell Populations in the Endometrium

Study ID: NCT06826365
Start Date: 2025-07-01
End Date: 2026-06-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Percentage distribution of immune system cells in peripheral blood

Percentage distribution of immune system cells in endometrium

Sponsor

Year of the Year.

Source: clinicaltrials.gov

Share:
Add to list

Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients with Locally Advanced Pancreatic Adenocarcinoma (LAPC)

Study ID: NCT06217666
Start Date: 2025-06-01
End Date: 2028-01-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

24

Intervention / Treatment

PCX-12

Sponsor

ha o name (Carl) Q IU

Source: clinicaltrials.gov

Share:
Add to list

A Phase Ib Study of RC1416 Injection

Study ID: NCT06911866
Start Date: 2025-05-25
End Date: 2026-01-02
Study Type

Interventional

Study Phase

Phase1

No. of Participants

40

Intervention / Treatment

RC1416

RC1416 Placebo

Sponsor

Nanjing RegeneCore Biotech Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome

Study ID: NCT06953466
Start Date: 2025-06-30
End Date: 2026-04-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

8

Intervention / Treatment

QRX003, 4% Lotion

Sponsor

Quoin Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list